The N-Terminus of gp130 is Critical for the Formation of the High-Affinity Interleukin-6 Receptor Complex

References

• de Serio A., Graziani R., Laufer R., Ciliberto G., Paonessa G. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. J. Mol. Biol. 1995; 254: 795–800
   PubMed Web of Science ®Google Scholar
• de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992; 255: 306–312
   PubMed Web of Science ®Google Scholar
• Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990; 61: 341–350
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis B., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: An Oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
   PubMed Web of Science ®Google Scholar
• Goochee C. F., Gramer M. J., Andersen D. C., Bahr J. B., Rasmussen J. R. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharidc structure and their effect on glycoprotein properties. Bio/Technology 1991; 9: 1347–1355
   Google Scholar
• Guschin D., Rogers N., Briscoe J., Witthuhn B., Watling D., Horn F., Pellegrini S., Yasukawa K., Heinrich P., Stark G. R., Ihle J. N., Kerr I. M. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995; 14: 1421–1429
   PubMed Web of Science ®Google Scholar
• Hammacher A., Simpson R. J., Nice E. C. The interleukin-6 (IL-6) partial antagonist (Q159E,T162P)IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex. J. Biol. Chem. 1996; 271: 5464–5473
   Google Scholar
• Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149–1157
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Nicola N. A., Gough N. M., Metcalf D. Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine mycloid leukemic cell lines. J. Biol. Chem. 1988; 263: 9238–9243
   PubMed Web of Science ®Google Scholar
• Hiraoka O., Anaguchi H., Asakura A., Ota Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J. Biol. Chem. 1995; 270: 25928–25934
   PubMed Web of Science ®Google Scholar
• Ip N. Y., Nye S. H., Boulton T. G., Davis S., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J., Stahl N., Yancopoulos D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121–1132
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell 1994; 76: 253–262
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86: 1243–1254
   PubMed Web of Science ®Google Scholar
• Lai C. F., Ripperger J., Morella K. K., Wang Y., Gearing D. P., Horseman N. D., Campos S. P., Fey G. H., Baumann H. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoictin receptors and control transcription via separate cytokine response elements. J. Biol. Chem. 1995; 270: 23254–23527
   PubMed Web of Science ®Google Scholar
• Larsen A., Davis T., Curtis B. M., Gimpel S., Sims J. E., Cosman D., Park L., Sorensen E., March C. J., Smith C. A. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J. Exp. Med. 1990; 172: 1559–1570
   PubMed Web of Science ®Google Scholar
• Modrell B., Liu J., Miller H., Shoyab M. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. Growth Factors 1994; 11: 81–90
   PubMed Web of Science ®Google Scholar
• Moore P. S., Boshoff C., Weiss R. A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739–1744
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa Y., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Paonessa G., Graziani R., de Serio A., Savino R., Ciapponi L., Lahm A., Salvati A. L., Toniatti C., Ciliberto G. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J. 1995; 14: 1942–1951
   PubMed Web of Science ®Google Scholar
• Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. J. Biol. Chem. 1995; 270: 10915–10922
   PubMed Web of Science ®Google Scholar
• Saito T., Taga T., Miki D., Futatsugi K., Yawata H., Kishimoto T., Yasukawa K. Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functions. J. Immunol. Methods 1993; 163: 217–223
   Google Scholar
• Simpson R. J., Hammacher A., Smith D. K., Matthews J. M., Ward L. D. Interleukin-6: structure-function relationships. Prot. Sci. 1997; 6: 929–955
   PubMed Web of Science ®Google Scholar
• Somers W., Ultsch M., de Vos A. M., Kossiakoff A. A. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 1994; 372: 478–481
   PubMedGoogle Scholar
• Sporeno E., Barbato G., Graziani R., Pucci P., Nitti G., Paonessa G. Production and structural characterization of amino terminally histidine tagged human oncostatin M i. E. coli. Cytokine 1994; 6: 255–264
   Google Scholar
• Taga T., Hibi M., Hirata Y., Yamasaki K., Masuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573–581
   PubMed Web of Science ®Google Scholar
• Tu G. F., Reid G. E., Zhang J. G., Moritz R. L., Simpson R. J. C-terminal extension of truncated recombinant proteins in Escherichia coli with a 10Sa RNA decapeptide. J. Biol. Chem. 1995; 270: 9322–9326
   PubMed Web of Science ®Google Scholar
• Ward L. D., Howlett G. J., Discolo G., Yasukawa K., Hammacher A., Moritz R. L., Simpson R. J. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp130. J. Biol. Chem. 1994; 269: 23286–23289
   PubMed Web of Science ®Google Scholar
• Ward L. D., Howlett G. J., Hammacher A., Weinstock J., Yasukawa K., Simpson R. J., Winzor D. Use of a biosensor with surface plasmon resonance detection for the determination of binding constants: measurement of interleukin-6 binding to the soluble interleukin-6 receptor. Biochemistry 1995; 34: 2901–2907
   PubMedGoogle Scholar
• Ward L. D., Hammacher A., Howlett G. J., Matthews J. M., Fabri L., Moritz R. L., Nice E. C., Weinstock J., Simpson R. J. Influence of interleukin-6 (IL-6) dimerization on formation of the high-affinity hexameric IL-6 receptor complex. J. Biol. Chem. 1996; 271: 20138–20144
   PubMed Web of Science ®Google Scholar
• Wilson I. A., Stanfield R. L. Antibody—Antigen interactions. Curr. Opin. Struct. Biol. 1993; 3: 113–118
   Web of Science ®Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Yasukawa K., Saito T., Fukunaga T., Sekimori Y., Koishihara Y., Fukui Y., Ohsugi Y., Matsuda T., Yawata H., Hirano T., Taga T., Kishimoto T. Purification and characterization of soluble human IL-6 receptorexpressed in CHO cells. J. Biochem. (Tokyo) 1990; 108: 673–676
   PubMedGoogle Scholar
• Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki H., Suzuki H., Taga T., Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 1992; 31: 123–130
   PubMed Web of Science ®Google Scholar
• Yin T., Taga T., Tsang L., Yasukawa K., Kishimoto T., Yang Y.-C. Involvement of IL-6 signal transducer gp130in IL-11-mediated signal transduction. J. Immunol. 1993; 151: 2555–2561
   PubMed Web of Science ®Google Scholar
• Zhang J. G., Moritz R. L., Reid G. E., Ward L. D., Simpson R. J. Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms. Eur. J. Biochem. 1992; 207: 903–913
   Google Scholar
• Zhang J. G., Owczarek C. M., Ward L. D., Howlett G. J., Fabri L. J., Roberts B. A., Nicola N. A. Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution. Biochem. J. 1997; 325: 693–700
   Google Scholar
• Zhang J. G., Zhang Y., Owczarek C. M., Ward L. D., Moritz R. L., Simpson R. J., Yasukawa K., Nicola N. A. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor α-chain in normal human urine and plasma. J. Biol. Chem. 1998; 273: 10798–10805
   PubMed Web of Science ®Google Scholar